{"disease":{"id":"wiskott-aldrich-syndrome","name":"wiskott aldrich syndrome"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05687474","title":"Baby Detect : Genomic Newborn Screening","phase":"","overall_status":"COMPLETED","enrollment_count":6824,"lead_sponsor_name":"Centre Hospitalier Universitaire de Liege","has_results":false},{"nct_id":"NCT01953016","title":"Participation in a Research Registry for Immune Disorders","phase":"","overall_status":"COMPLETED","enrollment_count":716,"lead_sponsor_name":"National Human Genome Research Institute (NHGRI)","has_results":false},{"nct_id":"NCT02064933","title":"Patients Treated for Wiskott-Aldrich Syndrome (WAS) Since 1990","phase":"","overall_status":"COMPLETED","enrollment_count":305,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":false},{"nct_id":"NCT00006319","title":"Molecular and Clinical Studies of Primary Immunodeficiency Diseases","phase":"","overall_status":"UNKNOWN","enrollment_count":266,"lead_sponsor_name":"National Human Genome Research Institute (NHGRI)","has_results":false},{"nct_id":"NCT01529827","title":"Fludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":94,"lead_sponsor_name":"Roswell Park Cancer Institute","has_results":true},{"nct_id":"NCT03333486","title":"Fludarabine Phosphate, Cyclophosphamide, Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Blood Cancer","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":31,"lead_sponsor_name":"Roswell Park Cancer Institute","has_results":true},{"nct_id":"NCT03399461","title":"Targeted Literature Review and Subject Interviews in Wiskott-Aldrich Syndrome (WAS)","phase":"","overall_status":"COMPLETED","enrollment_count":19,"lead_sponsor_name":"GlaxoSmithKline","has_results":false},{"nct_id":"NCT01515462","title":"Gene Therapy for Wiskott-Aldrich Syndrome","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":8,"lead_sponsor_name":"Fondazione Telethon","has_results":true},{"nct_id":"NCT03513328","title":"Conditioning Regimen for Allogeneic Hematopoietic Stem-Cell Transplantation","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":6,"lead_sponsor_name":"University of Florida","has_results":true},{"nct_id":"NCT03198195","title":"Post-transplant Cyclophosphamide in Wiskott-Aldrich Syndrome","phase":"","overall_status":"UNKNOWN","enrollment_count":5,"lead_sponsor_name":"Capital Research Institute of Pediatrics","has_results":false}],"total":10},"guidelines":[],"source":"Drug Landscape verified database"}